- Home
- CNOB vs YDES Comparison
CNOB vs YDES Comparison
Compare CNOB & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNOB
- YDES
- Stock Information
- Founded
- CNOB 1982
- YDES 2013
- Country
- CNOB United States
- YDES Taiwan
- Employees
- CNOB N/A
- YDES N/A
- Industry
- CNOB Major Banks
- YDES
- Sector
- CNOB Finance
- YDES
- Exchange
- CNOB Nasdaq
- YDES Nasdaq
- Market Cap
- CNOB 1.3B
- YDES 1.1B
- IPO Year
- CNOB 1996
- YDES N/A
- Fundamental
- Price
- CNOB $25.63
- YDES $18.00
- Analyst Decision
- CNOB Buy
- YDES
- Analyst Count
- CNOB 1
- YDES 0
- Target Price
- CNOB $31.00
- YDES N/A
- AVG Volume (30 Days)
- CNOB 322.5K
- YDES 103.6K
- Earning Date
- CNOB 10-23-2025
- YDES 09-30-2025
- Dividend Yield
- CNOB 2.74%
- YDES N/A
- EPS Growth
- CNOB N/A
- YDES N/A
- EPS
- CNOB 0.80
- YDES N/A
- Revenue
- CNOB $241,854,000.00
- YDES $510,360.00
- Revenue This Year
- CNOB $50.62
- YDES N/A
- Revenue Next Year
- CNOB $28.54
- YDES N/A
- P/E Ratio
- CNOB $32.98
- YDES N/A
- Revenue Growth
- CNOB N/A
- YDES 45.76
- 52 Week Low
- CNOB $20.61
- YDES $5.30
- 52 Week High
- CNOB $29.31
- YDES $25.00
- Technical
- Relative Strength Index (RSI)
- CNOB 54.11
- YDES N/A
- Support Level
- CNOB $24.90
- YDES N/A
- Resistance Level
- CNOB $26.06
- YDES N/A
- Average True Range (ATR)
- CNOB 0.61
- YDES 0.00
- MACD
- CNOB -0.01
- YDES 0.00
- Stochastic Oscillator
- CNOB 48.87
- YDES 0.00
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.